Science, innovation and commitment

Mutation in DOCK11 gene explains rare disorder in immune system regulation

Researchers from the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital participate in an international study, published in the prestigious scientific journal New England Journal of Medicine, which describes for the first time a new disease of the immune system caused by a mutation of the DOCK11 gene.

IRSJD and IRB Barcelona strengthen their research collaboration in pediatric cancer

The agreement includes the opening of a laboratory, led by Dr. Alexandra Avgustinova, which will address the specific vulnerabilities of developmental tumours to discover new therapeutic approaches. The shared Pediatric Cancer Epigenetics laboratory will be located on IRB Barcelona premises.

The first clinical trial of a gene therapy for Duchenne in children under 4 years old is initiated.

A research team from the Institut de Recerca Sant Joan de Déu · SJD Barcelona Children's Hospital is participating in an international clinical trial of a gene therapy for Duchenne muscular dystrophy in children under 4 years old.

Nanomedicine to tackle rare diseases

Experts in nanomedicine from various fields have gathered today for the fifth consecutive year at Nano Rare Diseases Day. This event is co-organized by IRSJD and the NANOMED Spain platform, coordinated by IBEC.

Agenda

#NeuroConCiencia| Biophysical modelling of non-invasive neuroscience

Speakers: Marc Schwartz Pallejà, PhD Student

Online

8h

Barcelona Medical Photonics Network 2024

The Barcelona Medical Photonics Network aims to bring cutting-edge photonic technologies to clinical research and ultimately to routine clinical use through the interdisciplinary cooperation of sixteen prominent institutions in Barcelona.

Auditori Plaza, Hospital Sant Joan de Déu

9:30h a 15h

Interviews

Manel González-Piñero

Headof Innovation at CREB UPC and XarTEC SALUT

"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."

Read more More Interviews